Results 231 to 240 of about 24,941 (289)

ADAM17 and its proteolytic targets in disease pathogenesis

open access: yesThe FEBS Journal, EarlyView.
ADAM17 as a multifunctional sheddase with contrasting roles across inflammatory, metabolic, cardiovascular, and neoplastic diseases. Through regulated activation by iRhom, iTAP/FRMD8, and tetraspanins, ADAM17 cleaves diverse membrane ligands and receptors, thereby promoting inflammation, fibrosis, obesity, insulin resistance, and tumor progression ...
Abdulbasit Amin, Marina Badenes
wiley   +1 more source

Proteolytic remodelling of the extracellular matrix by pericytes

open access: yesThe FEBS Journal, EarlyView.
Pericytes are specialised perivascular cells intimately connected with endothelial cells and essential for the maintenance of vascular beds. They contribute to the formation and remodelling of the extracellular matrix by actively secreting proteases and protease inhibitors.
Tina Burkhard   +4 more
wiley   +1 more source

Therapy of feto-placental insufficiency with xanthinol-nicothinate,glucose and insulin

open access: yes, 1975
CARLOMAGNO, Giorgio   +4 more
core  

Dialysis and Pregnancy: Optimizing Therapy for Best Maternal and Fetal Outcomes

open access: yesHemodialysis International, EarlyView.
ABSTRACT Pregnancy in women with end‐stage kidney disease (ESKD) requiring dialysis remains high risk, with significant maternal and fetal complications. While fertility rates are markedly reduced in this population, advances in dialysis care and obstetric management have led to increasing reports of successful pregnancies.
Shreepriya Mangalgi, Silvi Shah
wiley   +1 more source

Placental insufficiency

open access: yesIrish Journal of Medical Science, 1961
info:eu-repo/semantics ...
Wilkin, Paul
openaire   +5 more sources

The role of melatonin in pregnancies complicated by placental insufficiency: A systematic review [PDF]

open access: yesEuropean Journal of Obstetrics, Gynecology and Reproductive Biology, 2022
Placental insufficiency affects about 10% of pregnancies and can lead to pre-eclampsia, fetal growth restriction, and preterm birth. Despite significant advances in early prediction and prevention of preterm pre-eclampsia with aspirin, the effects of ...
Ilaria Fantasia   +2 more
exaly   +2 more sources

Nanomedicines: An approach to treat placental insufficiency and the current challenges [PDF]

open access: yesJournal of Controlled Release, 2023
INTRODUCTION: Preeclampsia and fetal growth restriction are common pregnancy complications that significantly impact perinatal health and offspring development later in life.
A T Lely
exaly   +1 more source

Definitions and reporting of placental insufficiency in biomedical journals: a review of the literature

open access: yesEuropean Journal of Obstetrics, Gynecology and Reproductive Biology, 2016
Placental insufficiency is a major problem worldwide for both mothers and babies. However, we have demonstrated in a review of the biomedical literature, that both the terminology used to describe, and techniques used to measure suboptimal placental ...
Stephen Kennedy, Manu Vatish
exaly   +2 more sources

Unfractionated heparin for second trimester placental insufficiency: a pilot randomized trial

open access: yesJournal of Thrombosis and Haemostasis, 2011
Objective: To conduct a pilot randomized controlled trial of unfractionated heparin (UFH) in women considered at high risk of placental insufficiency in the second trimester. Methods: Women with either false-positive first trimester (pregnancy-associated
J C P Kingdom, M Walker, Sarah Keating
exaly   +2 more sources

Placental insufficiency and postmaturity

European Journal of Obstetrics & Gynecology and Reproductive Biology, 1975
Full placental development and functioning are achieved around the 5th month of gestation. Thereafter, until birth, signs of gradual placental aging are observed which are partly compensated by an increase in trophoblastic surface area to maintain adequate fetal oxygen and nutrient supply (Krantz and Kubli, 1967; Hellegers, 1969).
openaire   +2 more sources

Home - About - Disclaimer - Privacy